Cassandra Protocol
S01E22 : IN-VIVO GENE SURGERY 2/3: BEAM THERAPEUTICS
The file bled through the architecture. Act One of a systemic biotech collapse is written in the liver. Welcome to the Cassandra Protocol. Watch it burn.
sector-health
Beam Therapeutics
AUDIT: Beam Therapeutics: The Clinical Dead Zone
A forensic audit of Beam Therapeutics (BEAM-302) reveals severe liver toxicity, a 12-month FDA hold, and executive de-risking in the gene surgery space.
Cassandra Protocol
S01E16 : IN-VIVO GENE SURGERY 1/3 : INTELLIA
The server room hums a frequency that shouldn't exist. The Cassandra Protocol decrypts the Gene Surgery Archive. We are logging the biological debt.
Intellia Therapeutics
AUDIT: Intellia: The Biological API & the Sepsis Pivot
Audit of Intellia Therapeutics' in-vivo CRISPR trials. Examining the MAGNITUDE Phase 3 data, the 'Sepsis Pivot', and the severe clinical solvency risks.
Tech Fail
NOTES: Intellia: A Cure So Good It Might Bankrupt You
Intellia promises a one-time genetic cure, but their CRISPR tech is like throwing a spanner in a Swiss watch. Unpacking the Ostrich Algorithm and spin.
The Cassandra Protocol
S01E12 : TELOMERE CLIFF 3/3 : UNITY BIOTECHNOLOGY
The servers hum in the Sedona heat. We recover the corrupted audio artifact of a $700M lie. The margin call on the human body has arrived. Listen closely.
Unity Biotechnology
AUDIT: Unity Biotechnology: Auditing Metabolic Bankruptcy and Senolytic Insolvency
Audit the $700M collapse of Unity Biotech. Explore the clinical failure of senolytics, SASP, and how metabolic bankruptcy led to DGCL 275 dissolution.
Zombie Cells
NOTES: Unity Biotechnology: The Cellular Margin Call
Unity Biotech promised to cure aging but burned $700M on a zombie cell hustle. A cynical dive into the Telomere Cliff and rotting from the inside out.
Cassandra Protocol
S01E07: TELOMERE CLIFF 2/3: ALTOS LABS
The Cassandra Protocol is active. Thermodynamic entropy does not accept venture capital. Uncover the dark reality of Altos Labs and our biological debt.
sector-health
NOTES: The Three-Billion-Dollar Banana Stand at the End of the World
Altos Labs is a $3 billion banana stand at the end of the world. Why billionaire tech bros are funding a terrifying, tumor-filled teratoma tightrope act.
Altos Labs
AUDIT: Altos Labs: Senolytic Insolvency, and the $3 Billion Biological Debt
A forensic audit of Altos Labs' $3B longevity pivot. Explore the biological reality of epigenetic reprogramming, senolytic insolvency, and FDA roadblocks.
Cassandra Protocol
S01E03: TELOMERE CLIFF 1/3: BIOAGE LABS
The Cassandra Protocol is active. BioAge sells a payday loan for the human chassis while the biological ledger collects. What wakes you when the fire hits?